Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]
News [12654]
Articles [175]
Editorials [5]
Conferences [248]
elearning [17]
Impact of culture, sociology and psychology on cancer and the role of AORTIC
Dr Jimmie Holland - Memorial Sloan Kettering Cancer Center, New York, U.S.A.
Impact of culture, sociology and psychology on cancer and the role of AORTIC ( Dr Jimmie Holland - Memorial Sloan Kettering Cancer Center, New York, U.S.A. )
5 May 2014
High levels of mutated p53 indicate metastatic phenotype
Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center...
High levels of mutated p53 indicate metastatic phenotype ( Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center, Houston, USA )
5 May 2014
New drug OTX15 shows early promise in fighting acute myeloid leukaemia
Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland
New drug OTX15 shows early promise in fighting acute myeloid leukaemia ( Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland )
5 May 2014
Personalisation of leukaemia treatment using genome sequencing
Dr Giovanni Martinelli - University of Bologna, Bologna, Italy
Personalisation of leukaemia treatment using genome sequencing ( Dr Giovanni Martinelli - University of Bologna, Bologna, Italy )
5 May 2014
History and ongoing work of AORTIC
Dr James Holland - Mount Sinai Hospital, New York, USA
History and ongoing work of AORTIC ( Dr James Holland - Mount Sinai Hospital, New York, USA )
5 May 2014
AORTIC and the benefits of coordination between different US NCI-designated...
Dr Lisa Stevens - National Cancer Institute, Bethesda, USA
AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya ( Dr Lisa Stevens - National Cancer Institute, Bethesda, USA )
5 May 2014
Subset of breast cancer patients found to benefit from neratinib in latest trial
Dr John W. Park - University of California San Francisco, San Francisco, USA
Subset of breast cancer patients found to benefit from neratinib in latest trial ( Dr John W. Park - University of California San Francisco, San Francisco, USA )
1 May 2014
New antibody-drug conjugate shows early promise against all forms of melanoma
Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA
New antibody-drug conjugate shows early promise against all forms of melanoma ( Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA )
1 May 2014
Phase II trial shows dacomitinib benefits a subgroup of patients with head and...
Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of...
Phase II trial shows dacomitinib benefits a subgroup of patients with head and neck cancer ( Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of Korea )
1 May 2014
Phase I trial shows the benefits of OTX015 in treating blood cancer
Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland
Phase I trial shows the benefits of OTX015 in treating blood cancer ( Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland )
1 May 2014
"Exciting" implications of bemacyclib study in the treatment of breast cancer
Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio...
"Exciting" implications of bemacyclib study in the treatment of breast cancer ( Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA )
1 May 2014
Immunotherapy in melanoma
Dr Adil I. Daud - University of California San Francisco School of Medicine...
Immunotherapy in melanoma ( Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA )
1 May 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation